CLINICAL PHARMACOTHERAPY DECISION ATLAS 2025–2026: The Evidence-Based Prescriber’s Workbook for Rapid Drug Selection, Addiction Management Psychedelic-Adjunct Therapies (English Edition)

Resenha de Benjamin , Emily | Editora

Onde comprar e compartilhar

Selo de recomendação Leitor Beta
Capa do livro CLINICAL PHARMACOTHERAPY DECISION ATLAS 2025–2026: The Evidence-Based Prescriber’s Workbook for Rapid Drug Selection, Addiction Management  Psychedelic-Adjunct Therapies (English Edition) por Benjamin , Emily

Preço: 24.99 BRL

Editora:

ASIN: B0FWR1LYFF

Perguntas Frequentes sobre CLINICAL PHARMACOTHERAPY DECISION ATLAS 2025–2026: The Evidence-Based Prescriber’s Workbook for Rapid Drug Selection, Addiction Management Psychedelic-Adjunct Therapies (English Edition)

O autor de "CLINICAL PHARMACOTHERAPY DECISION ATLAS 2025–2026: The Evidence-Based Prescriber’s Workbook for Rapid Drug Selection, Addiction Management Psychedelic-Adjunct Therapies (English Edition)" é Benjamin , Emily , publicado pela .

O preço do livro "CLINICAL PHARMACOTHERAPY DECISION ATLAS 2025–2026: The Evidence-Based Prescriber’s Workbook for Rapid Drug Selection, Addiction Management Psychedelic-Adjunct Therapies (English Edition)" é 24.99 BRL. Você pode comprar na Amazon ou pesquisar na Shopee.

Você pode comprar "CLINICAL PHARMACOTHERAPY DECISION ATLAS 2025–2026: The Evidence-Based Prescriber’s Workbook for Rapid Drug Selection, Addiction Management Psychedelic-Adjunct Therapies (English Edition)" na Amazon Brasil. Também está disponível no Kindle Unlimited e Audible para assinantes.
Kindle Unlimited - Mais de um milhão de eBooks